Hepatology 2009 Current Perspectives on Chronic Liver Disease		(Recorded East Coast Satellite Broadcast Webcast)
			No CME credit available
	Natural History and Clinical Course of Chronic		(Symposium Webcast)
	Hepatitis B Presented by: Steven Han, MD		No CME credit available
	Optimizing Outcomes: Clinical Decisions in HBV		(Symposium Webcast)
	Resistance and Long Term Therapy		No CME credit available
	Management of HBV HBeAg Positive Patients -		(2 Webcasts)
	Presented by: Dr.Tram Tran & Dr. Mack Mitchell		No CME credit available
	Management of HBV HBeAg Negative Patients -		(2 Webcasts)
	Presented by: Dr. Naoky Tsai & Dr. Eddie Cheung		No CME credit available
	Current Guidelines in the Management of HBV		(Webcast)
	Patients		No CME credit available
	Managing Treatment Resistance in HBV Patients		(Webcast)
			No CME credit available

HBV 2009 Slides
New>  Managing Hepatitis B At Risk Community
Hepatitis B
HBV Slide Archive
HBV 2nd Edition Slides
Epidemiology and Natural History
Diagnosis and Monitoring
Treatment - General Overview			Treatment - Interferons
Treatment - Nucleos(t)ides			Treatment - Combination Therapy
Treatment Guidelines			Vaccination
HBV 1st Edition Slides
Epidemiology			Investigational Drugs
Natural History of Disease			Serologic Markers
Treatment Options			Treatment Overview
Update on HIV / HBV Co-infection

Celiac Disease as a Cause of Abnormal Transaminases in Chronic Hepatitis B Infection Clark LE, Herrera JL. PRACTICAL GASTROENTEROLOGY • DECEMBER 2003;27:50-51. Chronic Hepatitis B: Who and How to Treat Landreneau SW, Herrera JL. PRACTICAL GASTROENTEROLOGY • NOVEMBER 2007;31:25-40. Virologic response at 12 months of treatment predicts sustained antiviral efficacy in patients with adefovir-treated Lamivudine-resistant chronic hepatitis B Jung YK, Yeon JE, Han WS, Kim JH, Kim JH, Park JJ, Kim JS, Bak YT, Yoo W, Hong SP, Kim SO, Kwon SY, Byun KS, Lee CH. Gut Liver. 2010 Jun;4(2):212-8. Epub 2010 Jun 16. Correlation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of alpha-fetoprotein Lee IC, Huang YH, Chan CC, Huo TI, Chu CJ, Lai CR, Lee PC, Su CW, Hung HH, Wu JC, Lin HC, Lee SD. Liver Int. 2010 Jun 15. [Epub ahead of print] Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis Wu B, Li T, Chen H, Shen J. Value Health. 2010 Apr 30. [Epub ahead of print] Does chemotherapy prevent HBV-related hepatocellular carcinoma? Cons Colombo M. Dig Liver Dis. 2010 Jul;42 Suppl 3:S298-301. On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective Chien RN. J Gastroenterol Hepatol. 2010 May;25(5):852-7. Overlap/switch to adefovir monotherapy for lamivudine-resistant patients who responded to combination therapy: a pilot controlled study Aizawa M, Tsubota A, Fujise K, Sato K, Baba M, Takamatsu M, Namiki Y, Ohkusa T, Tajiri H. Intern Med. 2010;49(12):1067-72. Epub 2010 Jun 15. PNA Array for Detection of Point Mutations in Hepatitis B Virus Associated with Antiviral Resistance Jang H, Kim J, Choi JJ, Son Y, Park H. J Clin Microbiol. 2010 Jun 23. [Epub ahead of print] Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis Shi Z, Yang Y, Ma L, Li X, Schreiber A. Obstet Gynecol. 2010 Jul;116(1):147-59. Long-Term Outcome of Renal Transplant Recipients With Chronic Hepatitis B Infection-Impact of Antiviral Treatments Yap DY, Tang CS, Yung S, Choy BY, Yuen MF, Chan TM. Transplantation. 2010 Jun 17. [Epub ahead of print] Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients Suzuki F, Akuta N, Suzuki Y, Yatsuji H, Sezaki H, Arase Y, Hirakawa M, Kawamura Y, Hosaka T, Kobayashi M, Saitoh S, Ikeda K, Kobayashi M, Watahiki S, Kumada H. J Gastroenterol Hepatol. 2010 May;25(5):892-8. Chronic Viral Infections and Invasive Procedures: Risk of Vertical Transmission and Current Recommendations López M, Coll O. Fetal Diagn Ther. 2010 Jun 19. [Epub ahead of print] Cryoglobulinemic glomerulonephritis in chronic hepatitis B infection Enríquez R, Sirvent AE, Andrada E, Escolano C, Rodríguez JC, Millán I, Gutiérrez F, Amorós F. Ren Fail. 2010 May;32(4):518-22. Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection Yokosuka O, Takaguchi K, Fujioka S, Shindo M, Chayama K, Kobashi H, Hayashi N, Sato C, Kiyosawa K, Tanikawa K, Ishikawa H, Masaki N, Seriu T, Omata M. J Hepatol. 2010 Mar 24. [Epub ahead of print] Incidence and Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance: A Community-based Follow-up Study Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Wang LY, You SL, Iloeje UH, Chen CJ; R.E.V.E.A.L.-HBV Study Group. Gastroenterology. 2010 Apr 28. [Epub ahead of print] High Hepatitis B Viral Load Predicts Recurrence of Small Hepatocellular Carcinoma after Curative Resection Qu LS, Jin F, Huang XW, Shen XZ. J Gastrointest Surg. 2010 Apr 27. [Epub ahead of print] Liver transplant from Anti-HBc-positive, HBsAg-negative donor into HBsAg-negative recipient: is it safe? A systematic review of the literature. Avelino-Silva VI, D Albuquerque LA, Bonazzi PR, Song AT, Miraglia JL, de Brito Neves A, Abdala E. Clin Transplant. 2010 Apr 28. [Epub ahead of print] Hepatitis B virus infection and liver transplantation Kennedy M, Alexopoulos SP. Curr Opin Organ Transplant. 2010 May 4. [Epub ahead of print] Noninvasive markers to diagnose cirrhosis in patients with HBeAg positive chronic hepatitis: Do new biomarkers improve the accuracy? Park SH, Kim DJ, Cheong JY, Cho SW, Hwang SG, Lee YJ, Cho M, Yang JM, Kim YB. Clin Biochem. 2010 Apr 27. [Epub ahead of print] Prevention of hepatitis B virus reactivation in B-cell lymphoma patients receiving chemotherapy with rituximab Mimura N, Kojima H, Tsujimura H, Ise M, Sakai C, Fukai K, Yokosuka O, Kumagai K. Rinsho Ketsueki. 2010 Mar;51(3):213-5. Viral resistance in hepatitis B: prevalence and management Poordad F, Chee GM. Curr Gastroenterol Rep. 2010 Feb;12(1):62-9. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients Zheng MH, Shi KQ, Dai ZJ, Ye C, Chen YP. Clin Ther. 2010 Apr;32(4):649-58. Drug Delivery Systems and Liver Targeting for the Improved Pharmacotherapy of the Hepatitis B Virus (HBV) Infection Cuestas ML, Mathet VL, Oubiña JR, Sosnik A. Pharm Res. 2010 Mar 24. [Epub ahead of print] Multiple Clusters of Hepatitis Virus Infections Associated with Anesthesia for Outpatient Endoscopy Procedures Gutelius B, Perz JF, Parker MM, Hallack R, Stricof R, Clement EJ, Lin Y, Xia GL, Punsalang A, Eramo A, Layton M, Balter S. Gastroenterology. 2010 Mar 27. [Epub ahead of print] Hepatitis B Virus DNA in Saliva from children with Chronic Hepatitis B Infection: Implications for Saliva as a potential mode of horizontal transmission Heiberg IL, Hoegh M, Ladelund S, Niesters HG, Hogh B. Pediatr Infect Dis J. 2010 Mar 23. [Epub ahead of print] HBV replication is significantly reduced by IL-6 Kuo TM, Hu CP, Chen YL, Hong MH, Jeng KS, Liang CC, Chen ML, Chang C. J Biomed Sci. 2009 Apr 20;16:41. Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin Levast M, Larrat S, Thelu MA, Nicod S, Plages A, Cheveau A, Zarski JP, Seigneurin JM, Morand P, Leroy V. J Med Virol. 2010 Mar 24;82(5):747-754. [Epub ahead of print] Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review Saab S, Waterman B, Chi AC, Tong MJ. Liver Transpl. 2010 Mar;16(3):300-7. Chronic hepatitis B infection and risk of atherosclerosis-related mortality: A 17-year follow-up study based on 22,472 residents in Taiwan Wang CH, Chen CJ, Lee MH, Yang HI, Hsiao CK. Atherosclerosis. 2010 Mar 10. [Epub ahead of print] Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: Prevalence, racial/ethnic differences, and viral interactions Bini EJ, Perumalswami PV. Hepatology. 2009 Nov 30. [Epub ahead of print] Toward elimination and eradication of hepatitis B Chen DS. J Gastroenterol Hepatol. 2010 Jan;25(1):19-25 Hepatitis B and hepatocellular carcinoma Di Bisceglie A. Hepatology 2009;49(S6):S56-60) Identification of Acute Self-limited Hepatitis B among Patients Presenting with Hepatitis B Virus-related Acute Hepatitis: a Hospital-based Han YN. J Int Med Res. 2009 Nov-Dec;37(6):1952-60 What Made a Successful Hepatitis B Program for Reducing Liver Cancer Disparities: An Examination of Baseline Characteristics and Educational Intervention, Infection Status, and Missing Responses of At-Risk Asian Americans Hsu CE, Zhang G, Yan FA, Shang N, Le T. J Community Health. 2010 Feb 5. [Epub ahead of print] Hepatitis B and Hepatitis C Prevalence and Treatment Referral Among Asian Americans Undergoing Community-Based Hepatitis Screening Hwang JP, Mohseni M, Gor BJ, Wen S, Guerrero H, Vierling JM. Am J Public Health 2010[Epub ahead of print] Epdemiology of hepatitis B in the United States Kim RW. Hepatology 2009;49:S28-S34 The natural history of chronic hepatitis B virus infection McMahon B. Hepatology 2009;49(S6):S46-S55 Effect of Needle Length When Immunizing Obese Adolescents With Hepatitis B Vaccine Middleman AB, Anding R, Tung C. Pediatrics. 2010 Feb 8. [Epub ahead of print] NIH Consensus Development Conference Statement on Management of Hepatitis B October 20-22, 2008 Is response to antiviral treatment influenced by hepatitis B virus genotype? Raimondi S, Maisonneuve P, Bruno S, Mondelli MU. J Hepatol. 2010 Jan 6. [Epub ahead of print] Evaluation of the patient with hepatitis B Rotman Y, Brown T, Hoofnagle J. Hepatology 2009;49(S6):S22-S27 End points of therapy in chronic hepatitis B Si Ahmed SN, Ecochard M, Zoulim F. Expert Rev Gastroenterol Hepatol. 2010 Feb;4(1):37-49 Eliminating the Blood: Ongoing Outbreaks of Hepatitis B Virus Infection and the Need for Innovative Glucose Monitoring Technologies Thompson ND, Perz JF. J Diabetes Sci Technol. 2009 Mar 1;3(2):283-288 Treatment of hepatitis B virus-associated glomerulonephritis: A meta-analysis Zhang Y, Zhou JH, Yin XL, Wang FY. World J Gastroenterol. 2010 Feb 14;16(6):770-7 Evaluation of the patient with hepatitis B Rotman Y, Brown TA, Hoofnagle JH. Hepatology 2009;49(S5):S22-S27 Special populations with hepatitis B virus infection Peters MG. Hepatology 2009;49(S5):S146-S155 Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochrondrial toxicity Tateo M, Roque-Afonso AM, Antonini TM, Medja F, Lombes A, Jardel C, Teicher E, Sebagh M, Roche B, Castaing D, Samuel D, Duclos-Vallee JC.AIDS. 2009 May 4 (Epub ahead of print) Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study Loras C, Saro C, Gonzalez-Huix F, et al. Am J Gastroenterol 2009;104:57-63. Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B Marcellin P, Heathcote E, Buti M, et al. N Engl Med 2008;359:2442-2455. Hepatitis B: Reflections on the current approach to antiviral therapy Zoulim F, Perrillo R. J Hepatol 2008;48:S2-S19. Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations Tan J, Degertekin B, Wong S, Husain M, Oberhelman K, Lok A. J Hepatology 2008;48:391-398. High Viral Load and Hepatitis B Virus Subgenotype Ce Are Associated With Increased Risk of Hepatocellular Carcinoma Chan H, Tse C, Mo F, Koh J, Wong V, Wong G, Chan S, Yeo W, Sung J, Mok T. J Clin Oncol 26:177-182, 2008. HBeAg and Hepatitis B Virus DNA as Outcome Predictors During Therapy with Peginterferon Alfa-2a for HBeAg-Positive Chronic Hepatitis B Fried M, Piratvisuth T, Lau G, Marcellin P, Chow W, Cooksley G, Luo K, Paik S, Liaw Y, Button P, Popescu M. HEPATOLOGY 2008;47:428-434. Viral genotype and baseline load predict the reponse to adefovir treatment in lamivudine-resistant hepatitis B patients Buti M, Elefsiniotis I, Jardi R, Vargas V, Rodriguez-Frias F, Schapper M, Bonovas S, Esteban R. Journal of Hepatology 2007 ; 47:366-372. Development and Validation of a Disease-Targeted Quality of Life Instrument in Chronic Hepatitis B: The Hepatitis B Quality of Life Instrument, Version 1.0 Spiegel B, Bolus R, Han S, Tong M, Esrailian E, Talley J, Tran T, Smith J, Karsan H, Durazo F, Bacon B, Martin P, Younossi Z, Hwa-Ong S, Kanwal F. HEPATOLOGY 2007 ; 46:113-121. Incidence of Non-Hodgkin's Lymphoma Among Individuals with Chronic Hepatitis B Virus Infection Yood MU, Quesenberry CP, Guo D, Caldwell C, Wells K, Shan J, Sanders L, Skovron ML, Iloeje U, Manos MM. HEPATOLOGY 2007 ; 46:107-112. Randomized Controlled Study of Tenofovir and Adefovir in Chronic Hepatitis B Virus and HIV Infection: ACTG A5127 Peters M, Andersen J, Lynch P, Liu T, Alston-Smith B, Brosgart C, Jacobson J, Johnson V, Pollard R, Rooney J, Sherman K, Swindells S, Polsky B for the ACTG Protocol A5127 Team. HEPATOLOGY 2006 ; 44:110-1116 Past HBV Viral Load as a Predictor of Mortality and Morbidity from HCC and Chronic Liver Disease in a Prospective Study G. Chen et al. Am J Gastroenterol 2006; 101: 1797-1803 A Comparison of Entecavir and Lamivudine for HBeAg-Negative Chronic Hepatitis B C. Lai et al. NEJM 354:10 1011-1020 Mar 06 A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B T. Chang et al. NEJM 354:10 1001-1010 Mar 06 Treatment with Peg-Interferon a-2b for HbeAg-Positive Chronic Hepatitis B: HbsAg Loss Is Associated with HBV Genotype H. Flink et al. Am J Gastroenterol 2006 (Feb);101:297-303 Notes from the NIH on Hepatitis B Hepatology Vol 42 number 4 October 2005 p748.